David S Saperstein

Summary

Affiliation: University of Kansas Medical Center
Country: USA

Publications

  1. ncbi Management of myasthenia gravis
    David S Saperstein
    Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas 66160, USA
    Semin Neurol 24:41-8. 2004
  2. ncbi Current concepts and controversy in chronic inflammatory demyelinating polyneuropathy
    David S Saperstein
    Department of Neurology, The University of Kansas Medical Center, 1005B Wescoe, 3901 Rainbow Boulevard, Kansas City, KS 66160, USA
    Curr Neurol Neurosci Rep 3:57-63. 2003
  3. ncbi Challenges in the identification of cobalamin-deficiency polyneuropathy
    David S Saperstein
    Department of Neurology, University of Kansas Medical Center, Kansas City 66160, USA
    Arch Neurol 60:1296-301. 2003
  4. ncbi Isolated neck extensor myopathy: is it responsive to immunotherapy?
    Srikanth Muppidi
    Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX 75390 9129, USA
    J Clin Neuromuscul Dis 12:26-9. 2010
  5. ncbi Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis
    Steven A Greenberg
    Department of Neurology, Division of Neuromuscular Disease, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    Ann Neurol 57:664-78. 2005
  6. ncbi Chronic acquired demyelinating polyneuropathies
    David S Saperstein
    Phoenix Neurological Associates, 1331 North 7th Street, Suite 350, Phoenix, AZ 85006, USA
    Semin Neurol 28:168-84. 2008

Collaborators

Detail Information

Publications6

  1. ncbi Management of myasthenia gravis
    David S Saperstein
    Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas 66160, USA
    Semin Neurol 24:41-8. 2004
    ..There are several immunomodulating agents from which to choose; selection is based largely on time to clinical effect and adverse effects. This review will discuss the selection and use of therapies for patients with myasthenia gravis...
  2. ncbi Current concepts and controversy in chronic inflammatory demyelinating polyneuropathy
    David S Saperstein
    Department of Neurology, The University of Kansas Medical Center, 1005B Wescoe, 3901 Rainbow Boulevard, Kansas City, KS 66160, USA
    Curr Neurol Neurosci Rep 3:57-63. 2003
    ..This article reviews the common clinical, laboratory, and electrodiagnostic features of CIDP. In addition, current areas of uncertainty are discussed...
  3. ncbi Challenges in the identification of cobalamin-deficiency polyneuropathy
    David S Saperstein
    Department of Neurology, University of Kansas Medical Center, Kansas City 66160, USA
    Arch Neurol 60:1296-301. 2003
    ..Diagnosing cobalamin (Cbl) deficiency as a cause of polyneuropathy (PN) is problematic, as the frequency of both disorders increases with age, and serum Cbl levels can be difficult to interpret...
  4. ncbi Isolated neck extensor myopathy: is it responsive to immunotherapy?
    Srikanth Muppidi
    Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX 75390 9129, USA
    J Clin Neuromuscul Dis 12:26-9. 2010
    ..To determine if isolated neck extensor myopathy (INEM) is responsive to immunosuppressive treatment...
  5. ncbi Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis
    Steven A Greenberg
    Department of Neurology, Division of Neuromuscular Disease, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    Ann Neurol 57:664-78. 2005
    ....
  6. ncbi Chronic acquired demyelinating polyneuropathies
    David S Saperstein
    Phoenix Neurological Associates, 1331 North 7th Street, Suite 350, Phoenix, AZ 85006, USA
    Semin Neurol 28:168-84. 2008
    ..This article outlines an approach to the diagnosis and management of chronic acquired demyelinating polyneuropathies...